Latest News

21 April, 2017 –

Avalia presents latest research at the Neoantigen conference:

Avalia is attending the European Neoantigen Summit in Amsterdam, 24-26 April, presenting a poster introducing its powerful vaccine platform.  Please…

21 April, 2017 –

Meet with Avalia at BIO International Conference this June 2017:

Please contact us directly to arrange a time to meet or use the BIO One-on-One partnering portal to meet during…

21 April, 2017 –

Five-year research partnership:

Avalia's research partner, the Ferrier Research Institute at Victoria University of Wellington continues to pioneer new ground with Avalia's NKT…

23 December, 2016 –

Meet with Avalia’s CEO at Biotech Showcase in San Francisco, January 9-11, 2017:

Please contact us directly to arrange a time to meet.

1 October, 2015 –

NZ bioscience celebrates its innovators:

At the Annual NZ Bio award dinner, Wednesday night 23rd September, Dr Shivali Gulab was announced the Young Bioscientist of…

28 May, 2015 –

Avalia receives TechConnect Innovation Award:

TechConnect is proud to announce the annual TechConnect Innovation Awards. These Awards identify the top 20% of submitted opportunities as…

21 May, 2015 –

Wellington team seeks human trials for promising cancer vaccine:

Clinicians say immunotherapy is a revolution in the treatment of cancer as it harnesses the body's immune system to fight…

21 May, 2015 –

New Wellington company to develop potential treatment for treating cancer:

An immunotherapy technology for treating cancer and other diseases, jointly developed by Victoria University of Wellington’s Ferrier Research Institute and…

6 October, 2014 –

City scientists patent asthma breakthrough:

Wellington scientists have patented a ground-breaking vaccine for asthma. Trial results published today show the vaccine works in mice, preventing…

5 May, 2014 –


Developing ways to harness our immune system for optimal health and prevention of disease.